ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.62
      -0.19%
      Bitcoin
      64,978.93
      -0.25%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Arno Therapeutics Inc (CE) (ARNI)

      7. Arno Therapeutics Inc (CE) (ARNI) News

      ARNI

      Arno Therapeutics (CE) (ARNI)

      Arno Therapeutics Inc (CE)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:ARNI
      DateTimeSourceHeadlineSymbolCompany
      11/06/20134:50PMEdgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:48PMEdgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:43PMEdgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/05/201310:09AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/05/201310:09AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20137:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20137:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20137:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20137:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20137:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20137:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20135:01PMEdgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:ARNIArno Therapeutics Inc (CE)
      10/31/20135:01PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARNIArno Therapeutics Inc (CE)
      10/30/20139:31AMEdgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:ARNIArno Therapeutics Inc (CE)
      10/30/20139:30AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ARNIArno Therapeutics Inc (CE)
      10/30/20138:00AMGlobeNewswire Inc.Arno Therapeutics Completes $30.7 Million Financing, Recapitalization and 1-for-8 Reverse Stock SplitUSOTC:ARNIArno Therapeutics Inc (CE)
      10/29/20135:00PMGlobeNewswire Inc.Arno Therapeutics Data Supports Further Evaluation of Onapristone in Prostate CancerUSOTC:ARNIArno Therapeutics Inc (CE)
      10/17/20134:41PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARNIArno Therapeutics Inc (CE)
      10/11/20135:09PMEdgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:ARNIArno Therapeutics Inc (CE)
      10/11/20135:08PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ARNIArno Therapeutics Inc (CE)
      10/09/20135:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      09/28/20138:00AMGlobeNewswire Inc.Arno Therapeutics to Present Data Validating Target Biomarker at European Cancer Congress 2013USOTC:ARNIArno Therapeutics Inc (CE)
       Showing the most relevant articles for your search:USOTC:ARNI